Current Opinion in Gastroenterology最新文献

筛选
英文 中文
Immune markers of severe acute pancreatitis. 重症急性胰腺炎的免疫标记物。
IF 2.6 3区 医学
Current Opinion in Gastroenterology Pub Date : 2024-09-01 Epub Date: 2024-06-28 DOI: 10.1097/MOG.0000000000001053
Peter J Lee, Georgios I Papachristou, Cate Speake, Adam Lacy-Hulbert
{"title":"Immune markers of severe acute pancreatitis.","authors":"Peter J Lee, Georgios I Papachristou, Cate Speake, Adam Lacy-Hulbert","doi":"10.1097/MOG.0000000000001053","DOIUrl":"10.1097/MOG.0000000000001053","url":null,"abstract":"<p><strong>Purpose of review: </strong>Acute pancreatitis is a common acute inflammatory disorder of the pancreas, and its incidence has been increasing worldwide. Approximately 10% of acute pancreatitis progresses to severe acute pancreatitis (SAP), which carries significant morbidity and mortality. Disordered immune response to pancreatic injury is regarded as a key event that mediates systemic injury in SAP. In this article, we review recent developments in immune biomarkers of SAP and future directions for research.</p><p><strong>Recent findings: </strong>Given the importance of the NLRP3-inflammasome pathway in mediating systemic inflammatory response syndrome and systemic injury, recent studies have investigated associations of SAP with systemic levels of activators of NLRP3, such as the damage associated molecular patterns (DAMPs) for the first time in human SAP. For example, circulating levels of histones, mitochondrial DNAs, and cell free DNAs have been associated with SAP. A panel of mechanistically relevant immune markers (e.g., panel of Angiopoeitin-2, hepatocyte growth factor, interleukin-8 (IL-8), resistin and sTNF-α R1) carried higher predictive accuracies than existing clinical scores and individual immune markers. Of the cytokines with established relevance to SAP pathogenesis, phase 2 trials of immunotherapies, including tumor necrosis factor (TNF)-alpha inhibition and stimulation of IL-10 production, are underway to determine if altering the immunologic response can reduce the severity of acute pancreatitis (AP).</p><p><strong>Summary: </strong>Circulating systemic levels of various DAMPs and a panel of immune markers that possibly reflect activities of different pathways that drive SAP appear promising as predictive biomarkers for SAP. But larger multicenter studies are needed for external validation. Studies investigating immune cellular pathways driving SAP using immunophenotyping techniques are scarce. Interdisciplinary efforts are also needed to bring some of the promising biomarkers to the bedside for validation and testing for clinical utility. Studies investigating the role of and characterization of altered gut-lymph and gut-microbiota in severe AP are needed.</p>","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":" ","pages":"389-395"},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11305979/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bidirectional relationship between acute pancreatitis and pancreatic cancer. 急性胰腺炎与胰腺癌之间的双向关系。
IF 2.6 3区 医学
Current Opinion in Gastroenterology Pub Date : 2024-09-01 Epub Date: 2024-06-25 DOI: 10.1097/MOG.0000000000001051
Christie Y Jeon, Mustafa A Arain, Murray Korc, Richard A Kozarek, Anna E Phillips
{"title":"Bidirectional relationship between acute pancreatitis and pancreatic cancer.","authors":"Christie Y Jeon, Mustafa A Arain, Murray Korc, Richard A Kozarek, Anna E Phillips","doi":"10.1097/MOG.0000000000001051","DOIUrl":"10.1097/MOG.0000000000001051","url":null,"abstract":"<p><strong>Purpose of review: </strong>The burdens of pancreatic ductal adenocarcinoma (PDAC) and acute pancreatitis are increasing globally. We reviewed current literature on whether acute pancreatitis is a causal factor for PDAC and examined clinical manifestations of PDAC-associated acute pancreatitis.</p><p><strong>Recent findings: </strong>Recent findings detail the timing of acute pancreatitis before and after PDAC occurrence, further solidifying the evidence for PDAC-associated acute pancreatitis and for acute pancreatitis as a causal risk factor for PDAC. The risk of PDAC remains elevated above the general population in patients with distant history of acute pancreatitis. PDAC risk also increases with recurrent acute pancreatitis episodes, independent of smoking and alcohol. Mechanisms linking acute pancreatitis to PDAC include inflammation and neutrophil infiltration, which can be attenuated by suppressing inflammation and/or epigenetic modulation, thus slowing the progression of acinar-to-ductal metaplasia. Clinical presentation and management of acute pancreatitis in the context of PDAC are discussed, including challenges acute pancreatitis poses in the diagnosis and treatment of PDAC, and novel interventions for PDAC-associated acute pancreatitis.</p><p><strong>Summary: </strong>PDAC risk may be reduced with improved acute pancreatitis prevention and treatment, such as antiinflammatories or epigenetic modulators. Increased acute pancreatitis and PDAC burden warrant more research on better diagnosis and management of PDAC-associated acute pancreatitis.</p>","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":" ","pages":"431-438"},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11305936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updates and innovations in therapeutic endoscopy. 治疗性内窥镜的更新与创新。
IF 2.6 3区 医学
Current Opinion in Gastroenterology Pub Date : 2024-09-01 Epub Date: 2024-08-08 DOI: 10.1097/MOG.0000000000001042
Anthony N Kalloo
{"title":"Updates and innovations in therapeutic endoscopy.","authors":"Anthony N Kalloo","doi":"10.1097/MOG.0000000000001042","DOIUrl":"10.1097/MOG.0000000000001042","url":null,"abstract":"","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"40 5","pages":"329"},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141898825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imaging abnormalities of the pancreas in diabetes: implications for diagnosis and treatment. 糖尿病患者的胰腺成像异常:对诊断和治疗的影响。
IF 2.6 3区 医学
Current Opinion in Gastroenterology Pub Date : 2024-09-01 Epub Date: 2024-06-28 DOI: 10.1097/MOG.0000000000001054
Benjamin Spilseth, Evan L Fogel, Frederico G S Toledo, Martha Campbell-Thompson
{"title":"Imaging abnormalities of the pancreas in diabetes: implications for diagnosis and treatment.","authors":"Benjamin Spilseth, Evan L Fogel, Frederico G S Toledo, Martha Campbell-Thompson","doi":"10.1097/MOG.0000000000001054","DOIUrl":"10.1097/MOG.0000000000001054","url":null,"abstract":"<p><strong>Purpose of review: </strong>Radiographic imaging of the pancreas has drawn recent interest as pancreas volume may serve as a biomarker in identifying the likelihood of diabetes development, subtyping diabetes, and identifying prognostic indicators of poor ultimate outcomes. In this review, the role of pancreas imaging is discussed in various forms of diabetes including type 1 diabetes (T1D), type 2 diabetes (T2D), and diabetes of the exocrine pancreas, particularly diabetes following acute or chronic pancreatitis.</p><p><strong>Recent findings: </strong>Recent literature of quantitative pancreatic imaging correlating with various forms of diabetes was reviewed. Imaging-derived pancreas volumes are lower in individuals with diabetes, in particular those with T1D. Additionally, morphologic changes, enhancement characteristics, fat content, and MRI signal changes have been observed in different diabetes subtypes. These characteristics, as well as potential confounding variables, are reviewed. Additionally, future areas of research in MRI, CT radiomics, and pancreatitis-related imaging predictors of diabetes are discussed.</p><p><strong>Summary: </strong>Increased understanding of pancreas imaging features which predict diabetes and gauge prognosis has the potential to identify at-risk individuals and will become increasingly important in diabetes care. This article reviews the current knowledge of common pancreas imaging features as well as future directions of ongoing research in diabetes imaging.</p>","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":" ","pages":"381-388"},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11305921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare disparities in pancreatitis: knowledge gaps and next steps. 胰腺炎的医疗差距:知识差距和下一步行动。
IF 2.6 3区 医学
Current Opinion in Gastroenterology Pub Date : 2024-09-01 Epub Date: 2024-07-01 DOI: 10.1097/MOG.0000000000001058
Radmila Choate, David Bradley, Darwin Conwell, Cemal Yazici
{"title":"Healthcare disparities in pancreatitis: knowledge gaps and next steps.","authors":"Radmila Choate, David Bradley, Darwin Conwell, Cemal Yazici","doi":"10.1097/MOG.0000000000001058","DOIUrl":"10.1097/MOG.0000000000001058","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review examines current research on healthcare disparities in pancreatitis, identifies knowledge gaps, and proposes strategies to develop targeted multilevel interventions to address inequities in pancreatitis care.</p><p><strong>Recent findings: </strong>Current literature has identified patient, disease, and healthcare-level factors contributing to disparities in risk factors and health outcomes of pancreatitis. Moreover, social structures, economic systems, social vulnerability, and policy significantly influence the pancreatitis care continuum.</p><p><strong>Summary: </strong>Understanding the root causes of health inequities is critical to developing effective approaches for the prevention, early detection, and management of pancreatitis.</p>","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":" ","pages":"422-430"},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk and factors determining diabetes after mild, nonnecrotizing acute pancreatitis. 轻度非坏死性急性胰腺炎后患糖尿病的风险和决定因素。
IF 2.6 3区 医学
Current Opinion in Gastroenterology Pub Date : 2024-09-01 Epub Date: 2024-06-26 DOI: 10.1097/MOG.0000000000001055
Ariana Pichardo-Lowden, Mark O Goodarzi, Guru Trikudanathan, Jose Serrano, Kathleen M Dungan
{"title":"Risk and factors determining diabetes after mild, nonnecrotizing acute pancreatitis.","authors":"Ariana Pichardo-Lowden, Mark O Goodarzi, Guru Trikudanathan, Jose Serrano, Kathleen M Dungan","doi":"10.1097/MOG.0000000000001055","DOIUrl":"10.1097/MOG.0000000000001055","url":null,"abstract":"<p><strong>Purpose of review: </strong>Diabetes mellitus (DM) is relatively common following acute pancreatitis (AP), even after mild acute pancreatitis (MAP), the most frequent AP presentation, in which there is no overt beta cell injury. Post-AP related diabetes is widely misdiagnosed, resulting in potentially inappropriate treatment and worse outcomes than type 2 diabetes (T2D). Thus, it is important to understand risk across the spectrum of AP severity.</p><p><strong>Recent findings: </strong>Biological mechanisms are unclear and may include local and systemic inflammation leading to beta cell dysfunction and insulin resistance, altered gut barrier and/or gut peptides and possibly islet autoimmunity, though no studies have specifically focused on MAP. While studies examining clinical risk factors on MAP exclusively are lacking, there are studies which include MAP. These studies vary in scientific rigor, approaches to rule out preexisting diabetes, variable AP severity, diagnostic testing methods, and duration of follow-up. Overall, disease related factors, including AP severity, as well as established T2D risk factors are reported to contribute to the risk for DM following AP.</p><p><strong>Summary: </strong>Though numerous studies have explored risk factors for DM after AP, few studies specifically focused on MAP, highlighting a key knowledge gap that is relevant to the majority of patients with AP.</p>","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":" ","pages":"396-403"},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11305911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ideal strategy for nonvariceal upper gastrointestinal bleeding. 治疗非静脉性上消化道出血的理想策略。
IF 2.6 3区 医学
Current Opinion in Gastroenterology Pub Date : 2024-09-01 Epub Date: 2024-07-03 DOI: 10.1097/MOG.0000000000001043
Robert T Kavitt, Ian M Gralnek
{"title":"Ideal strategy for nonvariceal upper gastrointestinal bleeding.","authors":"Robert T Kavitt, Ian M Gralnek","doi":"10.1097/MOG.0000000000001043","DOIUrl":"10.1097/MOG.0000000000001043","url":null,"abstract":"<p><strong>Purpose of review: </strong>Over 300 000 hospital admissions in the United States each year are due to patients with upper gastrointestinal (GI) bleeding (UGIB). Common etiologies of nonvariceal UGIB include peptic ulcers, mucosal erosions of the esophagus, stomach or duodenum, Mallory-Weiss tears, Dieulafoy lesions, upper GI tract malignancy, or other etiology.</p><p><strong>Recent findings: </strong>Peptic ulcers classified as Forrest Ia, Ib, or IIa require endoscopic hemostasis, while IIb ulcers may be considered for endoscopic clot removal with endoscopic treatment of any underlying major stigmata. Endoscopic hemostasis for ulcers classified as Forrest IIc or III is not advised due to the low risk of recurrent bleeding. Endoscopic hemostasis in ulcer bleeding can be achieved using injection, thermal, and/or mechanical modalities.</p><p><strong>Summary: </strong>This review focuses on the currently recommended endoscopic therapies of patients presenting with acute nonvariceal upper gastrointestinal hemorrhage.</p>","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":" ","pages":"342-347"},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introduction to the issue: acute pancreatitis and related metabolic complications. 本期简介:急性胰腺炎及相关代谢并发症。
IF 2.6 3区 医学
Current Opinion in Gastroenterology Pub Date : 2024-09-01 Epub Date: 2024-08-08 DOI: 10.1097/MOG.0000000000001044
Dhiraj Yadav, Phil A Hart, Melena Bellin
{"title":"Introduction to the issue: acute pancreatitis and related metabolic complications.","authors":"Dhiraj Yadav, Phil A Hart, Melena Bellin","doi":"10.1097/MOG.0000000000001044","DOIUrl":"10.1097/MOG.0000000000001044","url":null,"abstract":"","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"40 5","pages":"379-380"},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141898823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current and future microbiome-based therapies in inflammatory bowel disease. 基于微生物组的炎症性肠病疗法的现状与未来。
IF 2.6 3区 医学
Current Opinion in Gastroenterology Pub Date : 2024-07-01 Epub Date: 2024-04-10 DOI: 10.1097/MOG.0000000000001027
Jonathan A Montrose, Satya Kurada, Monika Fischer
{"title":"Current and future microbiome-based therapies in inflammatory bowel disease.","authors":"Jonathan A Montrose, Satya Kurada, Monika Fischer","doi":"10.1097/MOG.0000000000001027","DOIUrl":"10.1097/MOG.0000000000001027","url":null,"abstract":"<p><strong>Purpose of review: </strong>The role of the microbiome and dysbiosis is increasingly recognized in the pathogenesis of inflammatory bowel disease (IBD). Intestinal microbiota transplant (IMT), previously termed fecal microbiota transplant has demonstrated efficacy in restoring a healthy microbiome and promoting gut health in recurrent Clostridioides difficile infection. Several randomized trials (RCTs) highlighted IMT's potential in treating ulcerative colitis, while smaller studies reported on its application in managing Crohn's disease and pouchitis.</p><p><strong>Recent findings: </strong>This review delves into the current understanding of dysbiosis in IBD, highlighting the distinctions in the microbiota of patients with IBD compared to healthy controls. It explores the mechanisms by which IMT can restore a healthy microbiome and provides a focused analysis of recent RCTs using IMT for inducing and maintaining remission in IBD. Lastly, we discuss the current knowledge gaps that limit its widespread use.</p><p><strong>Summary: </strong>The body of evidence supporting the use of IMT in IBD is growing. The lack of a standardized protocol impedes its application beyond clinical trials. Further research is needed to identify patient profile and disease phenotypes that benefit from IMT, to delineate key donor characteristics, optimize the delivery route, dosage, and frequency.</p>","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"40 4","pages":"258-267"},"PeriodicalIF":2.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141263466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammatory bowel diseases 2024. 2024 年炎症性肠病。
IF 2.6 3区 医学
Current Opinion in Gastroenterology Pub Date : 2024-07-01 Epub Date: 2024-06-06 DOI: 10.1097/MOG.0000000000001038
Matthew A Ciorba
{"title":"Inflammatory bowel diseases 2024.","authors":"Matthew A Ciorba","doi":"10.1097/MOG.0000000000001038","DOIUrl":"10.1097/MOG.0000000000001038","url":null,"abstract":"","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"40 4","pages":"233-234"},"PeriodicalIF":2.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141263504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信